Article
Patients with Gaucher disease display systemic elevation of ACE2, which is impacted by therapy status and genotype.
Molecular genetics and metabolism - 1 Jan 2000
Fokra Ahmad, Feldman Hagit Baris, Kurolap Alina, Kinaneh Safa, Abassi Zaid, Hershkovitz Tova
Abstract excerpt
Gaucher disease (GD) has a high carrier rate among Ashkenazi Jews.The most common disease-causing variant in this population N370S, is also prevalent pan-ethnically. This has led to speculations of some protective effect for carriers of this variant. During the recent COVID-19 pandemic, GD patients reportedly had a surprisingly low infection rate and mild symptoms considering their disease status. As SARS-CoV-2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.